you need to read the preso to appreciate the significance of today's ann. To start with, the result was outstanding and it further increases the likelihood of success for other 3 phase 2 trials as they are more or less similar. Importantly, Neuren OWN the full commercial rights of all these indications and the potential size of the patient pool is 5 times bigger than Retts. FURTHER - there are hundreds of other autism related syndromes this drug can target. It's no longer a one trick pony but a full pipeline of indications!
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-8405
-
-
- There are more pages in this discussion • 4,142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.01 |
Change
0.310(2.44%) |
Mkt cap ! $1.661B |
Open | High | Low | Value | Volume |
$13.02 | $13.06 | $12.89 | $5.737M | 441.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 1160 | $13.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.02 | 6196 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 1330 | 13.000 |
22 | 1444 | 12.990 |
13 | 1004 | 12.980 |
6 | 832 | 12.970 |
3 | 1035 | 12.960 |
Price($) | Vol. | No. |
---|---|---|
13.010 | 1617 | 18 |
13.020 | 6122 | 10 |
13.030 | 4446 | 7 |
13.040 | 2580 | 4 |
13.050 | 1356 | 6 |
Last trade - 15.08pm 17/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online